Ectodermal Dysplasia 1, Anhidrotic: Clinical Trials

1 trial for Ectodermal Dysplasia 1, Anhidrotic, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow Ectodermal Dysplasia 1, Anhidrotic: new trials by email Literature Review of Ectodermal Dysplasia 1, Anhidrotic trials Research Report on Ectodermal Dysplasia 1, Anhidrotic

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase 1, Open-label, Multicenter, Safety and Pharmacokinetic Study of EDI200
EDI200 - X-linked Hypohidrotic Ectodermal Dysplasia
Phase 1CompletedEdimer Pharmaceuticals62012-05-012013-11-27

Broader conditions

Abnormalities, Multiple (1)  ·  Congenital Abnormalities (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Ectodermal Dysplasia (1)  ·  Genetic Diseases, Inborn (1)  ·  Genetic Diseases, X-Linked (1)  ·  Skin Abnormalities (1)  ·  Skin Diseases (1)  ·  Skin Diseases, Genetic (1)  ·  Skin and Connective Tissue Diseases (1)

Interventions

Fc-EDA (1)

Sponsors

Edimer Pharmaceuticals (1)

Countries

United States (1)

Top investigators

James Maynard, MD (1)  ·  Ophir Klein, MD, PhD (1)